A 31-year-old woman with severe, treatment-resistant atypical depression has failed multiple antidepressant trials. She is currently taking fluoxetine 60 mg daily but remains profoundly symptomatic. Her psychiatrist decides to transition her to phenelzine.
Arrange the following clinical steps in the correct chronological sequence to safely and effectively execute this medication transition and its long-term management.
- 1Taper and completely discontinue the fluoxetine prescription.
- 2Maintain a strict medication-free interval of 5 weeks to ensure clearance of active metabolites.
- 3Initiate a tyramine-restricted diet and administer the first dose of phenelzine.
- 4Titrate the phenelzine dose upward while actively monitoring for orthostatic hypotension.
- 5If phenelzine is ultimately ineffective, mandate a 14-day washout period before initiating a new serotonergic agent.
Answer
The correct sequence begins with discontinuing fluoxetine, followed by a mandatory 5-week washout period. After the washout, phenelzine is initiated alongside a tyramine-restricted diet, followed by dose titration with orthostatic blood pressure monitoring. Finally, if phenelzine fails, a 2-week washout is required before starting a new serotonergic agent.
The correct sequence respects the unique pharmacokinetics of fluoxetine and the irreversible nature of MAOIs. Fluoxetine must be stopped, followed by a 5-week washout (due to norfluoxetine's long half-life). Phenelzine is then started alongside a low-tyramine diet to prevent hypertensive crisis. During titration, monitoring for orthostatic hypotension (the most common side effect) is critical. Finally, if phenelzine is stopped, a 14-day washout is required before starting a new serotonergic drug to allow for the regeneration of the MAO enzyme.
Step-by-Step Solution
Key Concept
Pharmacological transition protocols and washout periods between SSRIs and MAOIs.